Papers
1
Total Citations
14
H-Index
1
About
Vittorio Fusco is a leading surgical oncologist whose research focuses on optimizing treatment strategies for rectal cancer, particularly the timing of surgery after neoadjuvant chemoradiotherapy. His most notable contribution is the TiMiSNAR trial, a multicenter randomized controlled study that compared standard 8-week versus prolonged 12-week intervals to minimally invasive surgery following chemoradiation. This landmark work, which has garnered significant attention with 14 citations, addresses a critical clinical debate by investigating whether extended waiting periods allow for more complete tumor regression. Fusco’s research challenges conventional surgical timelines, aiming to improve pathological complete response rates and reduce recurrence. His work has directly influenced clinical protocols in colorectal oncology, offering evidence-based guidance for surgical planning. By systematically evaluating the relationship between chemoradiation timing and surgical outcomes, Fusco has advanced personalized treatment approaches, helping to refine the standard of care for rectal cancer patients. His contributions underscore the importance of rigorous clinical trials in shaping modern surgical practice.
Research Focus
Key Achievements
Top Papers
- 1